9-(2-hydroxy-3-nonyl)adenine has been researched along with 8-bromocyclic gmp in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curry, FE; He, P; Zeng, M | 1 |
| Davidov, T; Lazar, M; Molino, B; Rodriguez, R; Scholz, PM; Su, J; Tse, J; Weiss, HR; Zhang, Q | 1 |
| Arai, N; Hiramoto, K; Inui, M; Manganiello, VC; Morita, H; Murata, T; Shimizu, K; Tagawa, T | 1 |
3 other study(ies) available for 9-(2-hydroxy-3-nonyl)adenine and 8-bromocyclic gmp
| Article | Year |
|---|---|
Dominant role of cAMP in regulation of microvessel permeability.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Adenosine Triphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Bradykinin; Calcium-Calmodulin-Dependent Protein Kinases; Capillaries; Capillary Permeability; Cyclic AMP; Cyclic GMP; Dideoxyadenosine; Enzyme Inhibitors; Female; Isoquinolines; Male; Mesenteric Veins; Rana pipiens; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Sulfonamides; Venules | 2000 |
Reduction in interaction between cGMP and cAMP in dog ventricular myocytes with hypertrophic failure.
Topics: Adenine; Animals; Body Weight; Cardiotonic Agents; Cyclic AMP; Cyclic GMP; Dogs; Drug Interactions; Enzyme Inhibitors; Heart Failure; Hypertrophy, Left Ventricular; Milrinone; Myocardial Contraction; Myocytes, Cardiac; Organ Size; Signal Transduction | 2005 |
Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Humans; Melanoma; RNA Interference; RNA, Small Interfering; Rolipram | 2014 |